{"basic_info": {"ticker": "2390", "exchange": "XSHE", "bloomberg_ticker": "002390 CH Equity", "name": "GUIZHOU XINBANG PHARMACEUT-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "信邦制药", "period": "2020", "market_value": 13787980800, "total_income": 5845621525, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 5794617595, "business_income_over_total_income": 0.9912748490845892}, {"shariah_compliance": "unknown", "income": 51003929, "business_income_over_total_income": 0.008725150744342793}], "details": [{"business_activity_cn": "药品", "business_activity_en": "drug", "income": 4606686335, "business_income_over_total_income": 0.7880575769913534, "shariah_compliance": "compliant"}, {"business_activity_cn": "医疗器械", "business_activity_en": "medical instruments", "income": 822670767, "business_income_over_total_income": 0.14073281403554433, "shariah_compliance": "compliant"}, {"business_activity_cn": "医疗服务", "business_activity_en": "medical service", "income": 1967914743, "business_income_over_total_income": 0.3366476489426845, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他产品", "business_activity_en": "other products", "income": 51003929, "business_income_over_total_income": 0.008725150744342793, "shariah_compliance": "unknown"}, {"business_activity_cn": "合并抵消", "business_activity_en": "Merge offset", "income": -1602654250, "business_income_over_total_income": -0.2741631908849932, "shariah_compliance": "compliant"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.20270283015521787, "shariah_compliance": "non-compliant", "amount_over_market_value": 0.20270283015521787}]}